Certara (NASDAQ:CERT) Shares Down 3.1%

Certara, Inc. (NASDAQ:CERT)’s share price dropped 3.1% during trading on Thursday . The company traded as low as $13.44 and last traded at $13.51. Approximately 24,912 shares changed hands during mid-day trading, a decline of 96% from the average daily volume of 554,677 shares. The stock had previously closed at $13.94.

Analyst Upgrades and Downgrades

CERT has been the subject of a number of recent analyst reports. Jefferies Financial Group boosted their price objective on Certara from $14.00 to $15.50 and gave the company a “hold” rating in a research report on Friday, March 1st. UBS Group boosted their price objective on Certara from $17.00 to $20.00 and gave the company a “neutral” rating in a research report on Friday, March 1st. KeyCorp upgraded Certara from a “sector weight” rating to an “overweight” rating and set a $23.00 price objective for the company in a research report on Wednesday, April 10th. Finally, JMP Securities began coverage on Certara in a research report on Thursday, April 4th. They issued a “market perform” rating for the company. Seven equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $20.06.

Certara Price Performance

The company has a quick ratio of 3.26, a current ratio of 3.26 and a debt-to-equity ratio of 0.27. The company has a fifty day simple moving average of $16.12 and a 200-day simple moving average of $16.91.

Certara (NASDAQ:CERT) last issued its earnings results on Tuesday, May 7th. The company reported $0.06 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.07 by ($0.01). Certara had a negative net margin of 17.02% and a positive return on equity of 4.08%. The company had revenue of $96.65 million during the quarter, compared to analysts’ expectations of $94.48 million. As a group, equities analysts expect that Certara, Inc. will post 0.29 earnings per share for the current fiscal year.

Insider Activity

In related news, SVP Richard M. Traynor sold 3,000 shares of the stock in a transaction dated Monday, April 1st. The stock was sold at an average price of $18.00, for a total transaction of $54,000.00. Following the transaction, the senior vice president now owns 173,524 shares of the company’s stock, valued at approximately $3,123,432. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. In other Certara news, SVP Richard M. Traynor sold 3,000 shares of the company’s stock in a transaction dated Monday, April 1st. The stock was sold at an average price of $18.00, for a total transaction of $54,000.00. Following the sale, the senior vice president now owns 173,524 shares in the company, valued at approximately $3,123,432. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Patrick F. Smith sold 14,427 shares of the company’s stock in a transaction dated Tuesday, April 2nd. The stock was sold at an average price of $16.85, for a total value of $243,094.95. Following the sale, the insider now owns 50,091 shares in the company, valued at approximately $844,033.35. The disclosure for this sale can be found here. Corporate insiders own 2.39% of the company’s stock.

Institutional Investors Weigh In On Certara

Large investors have recently bought and sold shares of the stock. Pineridge Advisors LLC purchased a new position in shares of Certara in the 4th quarter valued at about $28,000. Global Retirement Partners LLC increased its holdings in shares of Certara by 5,306.3% in the 1st quarter. Global Retirement Partners LLC now owns 1,730 shares of the company’s stock valued at $31,000 after acquiring an additional 1,698 shares during the last quarter. YHB Investment Advisors Inc. purchased a new position in shares of Certara in the 1st quarter valued at about $47,000. Covestor Ltd increased its holdings in shares of Certara by 14,940.0% in the 3rd quarter. Covestor Ltd now owns 3,760 shares of the company’s stock valued at $55,000 after acquiring an additional 3,735 shares during the last quarter. Finally, Natixis Advisors L.P. increased its holdings in shares of Certara by 13.4% in the 3rd quarter. Natixis Advisors L.P. now owns 15,136 shares of the company’s stock valued at $220,000 after acquiring an additional 1,791 shares during the last quarter. Hedge funds and other institutional investors own 73.96% of the company’s stock.

About Certara

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.